Cyclic adenosine monophosphate-phosphodi
β
Robert L. Banner; William K. Vaughn; King A. Hagey; W. Joseph Thompson; Evan M.
π
Article
π
1977
π
John Wiley and Sons
π
English
β 564 KB
## Abstract In vivo skin tests using multiple recall and primary antigens such as dinitrochlorobenzine (DNCB) have established that there is decreased cellularβmediated immune response in patients with squamous cell carcinomas of the head and neck. In vitro testing of lymphocytes using blastogenic